ClinicalTrials.gg
RecruitingNCT04766801BariAdoUpdated Feb 23, 2021

Adolescents Bariatric Surgery Cohort Survey

An observational study in Bariatric Surgery Candidate, Obesity, Morbid and Obesity, Adolescent, sponsored by University Hospital, Angers. Recruiting at 1 site in France. Open to participants aged 14 Years to 20 Years. Per ClinicalTrials.gov, last updated 2021-02-23.

Sponsored by University Hospital, Angers · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2021, 5 years ago, but the record still lists the study as recruiting.
  • Started Jan 2008; still recruiting 18 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
14 Years to 20 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 66 studies in Obesity, Morbid with a site in France — 13 open to participants now, 15 under way, none of them phase 3. Obesity, Morbid · France.

Planned enrollment
15th of 23
100 · median 170
Started
2008
with 2 others
Observational
23 of 66
6 open now
Primary completion
2021-10
later than 0 of 14 live
Registered
50th of 66
by date

Among the 66 studies in Obesity, Morbid with a site in France, this one is the 15th largest by planned enrollment of the 23 observational ones that give a count, is one of 3 that started in 2008, is one of 23 observational ones, reaches primary completion later than 0 of the 14 other live ones, and was the 50th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

13 of the 66 studies in Obesity, Morbid with a site in France are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 14 Years to 20 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 66 studies in Obesity, Morbid with a site in France, or all of them as a file.
02

Study summary

Obesity affects 3%-4% of the pediatric population and leads to cardiac mortality during adult life. Bariatric surgery is the best treatment for weight loss and preventing obesity associated comorbidities in adults, but its applications and safety are yet to be defined for adolescents.

Read the detailed description

Since 2008, in France, certain university hospitals have been eligible to perform bariatric surgery for adolescents. It was therfore possible to define its feasibility, potential complications and specific indications.

This led to recommandations published by Health Authorities (HAS) in 2016. However, it seems imperative to continue monitoring these patients in order to improve their management, especially as the use of these surgical techniques becomes increasingly widespread.

The Angers University Hospital is one of the leading hospitals when it comes bariatric surgery for adolescents through its use of gastric bands.

The aim of this protocol is to update data on how effective this surgery is on weight loss and obesity-associated comorbidities, and to monitor medical, psychological and surgical complications associated with this treatment.

03

Conditions studied

  • Bariatric Surgery Candidate
  • Obesity, Morbid
  • Obesity, Adolescent

Keywords

  • gastric banding
  • complications
  • weight loss
04

Who can participate

Ages eligible
14 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patients treated in our hospital for morbid obesity (BMI >= 35 Kg.M-2) through different programs with lifestyle and nutritional interventions and, for those who requested it, the possibility of bariatric surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 14-20 years of age and asking for bariatric surgery
  • >= 40 Kg.m-2 or >= 35 Kg.m-2 with major obesity-related comorbidities (hypertension, diabetes, sleep apnea, etc...)

Exclusion criteria

Exclusion Criteria:

  • An unstable psychiatric disorder
  • Bariatric surgery anesthesic
  • Having not completed a minimum of six months of the pre operative program
  • Lack of consent from the patient or the patient's relatives.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • ProcedureLaparoscopic adjustable gastric banding

    Weight-loss surgery, with the use of gastric banding

06

What researchers measure

Primary outcomes

  1. Change of weight parameters at 2 years compared to preoperative baseline

    Evaluation of weight loss by weight (Kg), body mass index (BMI, Kg.m-2) and excess body weight (EBWL, %) changes

    Time frame: 2 years

Secondary outcomes

  1. Changes of insulin resistance at 2 years

    Evaluation of insulin resistance by measure of the HOMA index

    Time frame: 2 years

  2. Evaluation of dyslipidemia

    Evaluation of lipid profile (cholesterol, triglycerides)

    Time frame: 2 years

  3. Evaluation of liver steatosis

    Evaluation of liver steatosis and NAFLD on US exam and liver elastometry

    Time frame: 2 years

  4. Resolution of comorbidities associated with obesity

    Clinical evaluation of the presence/absence of hypertension, sleep apnea, orthopedic disorders and polycystic ovary at two years, compared to Baseline characteristics

    Time frame: 2 years

  5. Monitoring of psychiatric profile

    Clinical evaluation of the presence/absence of psychiatric disorders such as binge eating, depression, etc...

    Time frame: 2 years

  6. Evaluation of quality of life

    Evaluation of obesity-related QOL by the use of the PedsQL scale

    Time frame: 2 years

  7. Evaluation of cosmetic satisfaction

    Evaluation of the patient's level of satisfaction with regards to their surgical scar using the POSAS scale

    Time frame: 12 months postoperative

  8. Surgical complications

    Monitoring of the occurrence of surgical complications and their severity thanks to the Clavien-Dindo scale at each medical consultation

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2008 (actual). Primary completion is estimated for Oct 2021, 165 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2020
First posted
Feb 23, 2021
StartActual
Jan 1, 2008
Primary completionEst.
Oct 31, 2021
CompletionEst.
Dec 31, 2030
Last update
Feb 23, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04766801
Responsible party
Sponsor
First posted
Feb 23, 2021
Start date
Jan 1, 2008
Primary completion
Oct 31, 2021 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Feb 23, 2021

Study contacts

Françoise Schmitt, MD-PhD
Contact
FrSchmitt@chu-angers.fr
0241354290 ext. +33
Régis Coutant, MD-PhD
Contact
ReCoutant@chu-anger.fr
0241355655 ext. +33
Françoise Schmitt, MD-PhD
principal investigator · University Hospital of Angers

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion